SCHEMBL4897406

SCHEMBL4897406

O=C(CC(=O)C(F)(F)F)c1cccc(Br)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
PLOD2 O00469 3/20 0.47
PLOD3 O60568 2/20 0.47
PLOD1 Q02809 2/20 0.47
GRM5 P41594 1/20 0.43
P2RX7 Q99572 2/20 0.41
CTSA P10619 1/20 0.39
CES1 P23141 1/20 0.37
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.35
KDM4E B2RXH2 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
ACMSD Q8TDX5 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
FAAH O00519 1/20 0.34
MAPK10 P53779 1/20 0.34
ACKR3 P25106 1/20 0.33
PTGS1 P23219 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7254186 0.82 PLOD2 (0.46) ALDH1A1HPGDPLOD2PLOD3PLOD1
SCHEMBL3511203 0.79 ALDH1A1 (0.49) ALDH1A1HPGDGRM5P2RX7CTSA
SCHEMBL20910130 0.79 ALDH1A1 (0.45) ALDH1A1HPGDGRM5P2RX7CTSA
SCHEMBL29567310 0.79 ALDH1A1 (0.45) ALDH1A1HPGDGRM5P2RX7CTSA
SCHEMBL17440847 0.79 ALDH1A1 (0.43) ALDH1A1HPGDGRM5P2RX7CTSA
SCHEMBL17449457 0.79 ALDH1A1 (0.43) ALDH1A1HPGDGRM5P2RX7CTSA
SCHEMBL12646638 0.78 PLOD2 (0.43) ALDH1A1PLOD2PLOD3PLOD1P2RX7
SCHEMBL15988712 0.78 ALDH1A1 (0.51) ALDH1A1HPGDGRM5P2RX7CTSA
SCHEMBL3508834 0.77 ALDH1A1 (0.50) ALDH1A1HPGDGRM5P2RX7CTSA
SCHEMBL31096237 0.77 ALDH1A1 (0.50) ALDH1A1HPGDGRM5P2RX7CTSA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12534458-B2 Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors MERCK SHARP & DOHME LLC (US) 2026-01-27 US disclosed
US-20220396571-A1 SPIROPIPERIDINE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS MERCK SHARP & DOHME CORP. (US) 2022-12-15 US disclosed
US-20080119488-A1 Modulators Of Nuclear Receptors EXELIXIS, INC. (US) 2008-05-22 US disclosed
US-20080119488-A1 Modulators Of Nuclear Receptors EXELIXIS, INC. (US) 2008-05-22 US disclosed
US-20080119488-A1 Modulators Of Nuclear Receptors EXELIXIS, INC. (US) 2008-05-22 US disclosed
EP-1773337-A2 MODULATORS OF NUCLEAR RECEPTORS Exelixis, Inc. (US) 2007-04-18 EP disclosed
WO-2006025979-A9 MODULATORS OF NUCLEAR RECEPTORS EXELIXIS INC (US) 2006-04-20 WO disclosed
WO-2006025979-A2 MODULATORS OF NUCLEAR RECEPTORS EXELIXIS, INC. (US) 2006-03-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12534458-B2 Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors CHRNA6, CHRNA7, CHRNA5 ALDH1A1 1569/4885HPGD 2098/4885PLOD2 4813/4885
US-20080119488-A1 Modulators Of Nuclear Receptors NR1H2, NR0B1, NR1H3 ALDH1A1 1094/4885HPGD 775/4885PLOD2 4633/4885
US-20220396571-A1 SPIROPIPERIDINE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS CHRNA7, CHRNA5, CHRNA6 ALDH1A1 1360/4885HPGD 965/4885PLOD2 4625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.